Presence and functional actions of In1-ghrelin splicing variant reveals a potentially relevant pathophysiological role in human pituitary adenomas
Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Raúl M. Luque(Instituto de Salud Carlos III), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Miguel Á. Japón(Instituto de Biomedicina de Sevilla), Eva Venegas‐Moreno(Hospital Universitario Virgen del Rocío), Michael D. Culler(Ipsen (United States)), la Riva Andres de, Esther Rivero‐Cortés(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Carlos Diéguez(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Richard L. Nelson(Illinois Department of Public Health), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Jennifer Morgan, Alfonso Soto‐Moreno(Instituto de Biomedicina de Sevilla), Natia Tsomaia(Ipsen (France)), Manuel Beltrán(Hospital Universitario Puerta del Mar), María A. Gálvez(Hospital Universitario Reina Sofía), Juan Antonio García-Arnés
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Does gut hormone PYY3–36 decrease food intake in rodents?
|Nature|2004|295
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251
The Opioid System and Food Intake: Homeostatic and Hedonic Mechanisms
|Obesity Facts|2012|147